Thursday 31 December 2009

Fluorouracilo Pfizer




Fluorouracilo Pfizer may be available in the countries listed below.


Ingredient matches for Fluorouracilo Pfizer



Fluorouracil

Fluorouracil is reported as an ingredient of Fluorouracilo Pfizer in the following countries:


  • Peru

International Drug Name Search

Monday 28 December 2009

Deltameth




Deltameth may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Deltameth



Methionine

Methionine is reported as an ingredient of Deltameth in the following countries:


  • Australia

International Drug Name Search

Thursday 24 December 2009

Decorex




Decorex may be available in the countries listed below.


Ingredient matches for Decorex



Dexamethasone

Dexamethasone is reported as an ingredient of Decorex in the following countries:


  • Peru

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Decorex in the following countries:


  • Mexico

International Drug Name Search

Vanacyclin




Vanacyclin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vanacyclin



Oxytetracycline

Oxytetracycline dihydrate (a derivative of Oxytetracycline) is reported as an ingredient of Vanacyclin in the following countries:


  • Austria

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Vanacyclin in the following countries:


  • Austria

International Drug Name Search

Wednesday 16 December 2009

Zolben




Zolben may be available in the countries listed below.


Ingredient matches for Zolben



Albendazole

Albendazole is reported as an ingredient of Zolben in the following countries:


  • Brazil

Paracetamol

Paracetamol is reported as an ingredient of Zolben in the following countries:


  • Chile

  • Switzerland

International Drug Name Search

Zeramec




Zeramec may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Zeramec



Ivermectin

Ivermectin is reported as an ingredient of Zeramec in the following countries:


  • South Africa

Zeranol

Zeranol is reported as an ingredient of Zeramec in the following countries:


  • South Africa

International Drug Name Search

Sunday 13 December 2009

Nifalin




Nifalin may be available in the countries listed below.


Ingredient matches for Nifalin



Lorazepam

Lorazepam is reported as an ingredient of Nifalin in the following countries:


  • Greece

International Drug Name Search

Saturday 12 December 2009

Zelface




Zelface may be available in the countries listed below.


Ingredient matches for Zelface



Azelaic Acid

Azelaic Acid is reported as an ingredient of Zelface in the following countries:


  • Indonesia

International Drug Name Search

Bemetrazole




Bemetrazole may be available in the countries listed below.


Ingredient matches for Bemetrazole



Metronidazole

Metronidazole is reported as an ingredient of Bemetrazole in the following countries:


  • South Africa

International Drug Name Search

Thursday 3 December 2009

Cavida




Cavida may be available in the countries listed below.


Ingredient matches for Cavida



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Cavida in the following countries:


  • Indonesia

Colecalciferol

Colecalciferol is reported as an ingredient of Cavida in the following countries:


  • Indonesia

International Drug Name Search

Wednesday 25 November 2009

Iodipine




Iodipine may be available in the countries listed below.


Ingredient matches for Iodipine



Apraclonidine

Apraclonidine hydrochloride (a derivative of Apraclonidine) is reported as an ingredient of Iodipine in the following countries:


  • Finland

International Drug Name Search

Tuesday 24 November 2009

Salbutamol Inhalation




Salbutamol Inhalation may be available in the countries listed below.


Ingredient matches for Salbutamol Inhalation



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbutamol Inhalation in the following countries:


  • Australia

International Drug Name Search

Monday 23 November 2009

Zelmac




Zelmac may be available in the countries listed below.


Ingredient matches for Zelmac



Tegaserod

Tegaserod is reported as an ingredient of Zelmac in the following countries:


  • Argentina

  • Bangladesh

  • Indonesia

Tegaserod maleate (a derivative of Tegaserod) is reported as an ingredient of Zelmac in the following countries:


  • Brazil

  • Chile

  • China

  • Colombia

  • Ecuador

  • Hong Kong

  • Israel

  • Malaysia

  • Mexico

  • Oman

  • Peru

  • Serbia

  • Singapore

  • Thailand

  • Venezuela

  • Vietnam

International Drug Name Search

Sunday 22 November 2009

Pantomicina ES




Pantomicina ES may be available in the countries listed below.


Ingredient matches for Pantomicina ES



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Pantomicina ES in the following countries:


  • Ecuador

International Drug Name Search

Wednesday 18 November 2009

Venlix




Venlix may be available in the countries listed below.


Ingredient matches for Venlix



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlix in the following countries:


  • Norway

International Drug Name Search

Pelias




Pelias may be available in the countries listed below.


Ingredient matches for Pelias



Allylestrenol

Allylestrenol is reported as an ingredient of Pelias in the following countries:


  • Japan

International Drug Name Search

Tuesday 17 November 2009

Maglax




Maglax may be available in the countries listed below.


Ingredient matches for Maglax



Magnesium Oxide

Magnesium Oxide is reported as an ingredient of Maglax in the following countries:


  • Japan

International Drug Name Search

Saturday 14 November 2009

Zolodorm




Zolodorm may be available in the countries listed below.


Ingredient matches for Zolodorm



Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolodorm in the following countries:


  • Argentina

International Drug Name Search

Friday 6 November 2009

Zobox




Zobox may be available in the countries listed below.


Ingredient matches for Zobox



Cilazapril

Cilazapril is reported as an ingredient of Zobox in the following countries:


  • Serbia

International Drug Name Search

Zinoxx




Zinoxx may be available in the countries listed below.


Ingredient matches for Zinoxx



Cefuroxime

Cefuroxime is reported as an ingredient of Zinoxx in the following countries:


  • Poland

International Drug Name Search

Tuesday 27 October 2009

Gilt




Gilt may be available in the countries listed below.


Ingredient matches for Gilt



Clotrimazole

Clotrimazole is reported as an ingredient of Gilt in the following countries:


  • Germany

International Drug Name Search

Saturday 24 October 2009

Lovinacor




Lovinacor may be available in the countries listed below.


Ingredient matches for Lovinacor



Lovastatin

Lovastatin is reported as an ingredient of Lovinacor in the following countries:


  • Italy

International Drug Name Search

Friday 23 October 2009

Sertralin Hexal




Sertralin Hexal may be available in the countries listed below.


Ingredient matches for Sertralin Hexal



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralin Hexal in the following countries:


  • Austria

  • Czech Republic

  • Denmark

  • Finland

  • Germany

  • Luxembourg

  • Sweden

International Drug Name Search

Monday 19 October 2009

Loxasid




Loxasid may be available in the countries listed below.


Ingredient matches for Loxasid



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Loxasid in the following countries:


  • Turkey

International Drug Name Search

Sunday 18 October 2009

Bezafibrat-1A Pharma




Bezafibrat-1A Pharma may be available in the countries listed below.


Ingredient matches for Bezafibrat-1A Pharma



Bezafibrate

Bezafibrate is reported as an ingredient of Bezafibrat-1A Pharma in the following countries:


  • Austria

  • Germany

International Drug Name Search

Zirtene




Zirtene may be available in the countries listed below.


Ingredient matches for Zirtene



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Zirtene in the following countries:


  • Ireland

International Drug Name Search

Tuesday 13 October 2009

Zomep




Zomep may be available in the countries listed below.


Ingredient matches for Zomep



Omeprazole

Omeprazole is reported as an ingredient of Zomep in the following countries:


  • India

International Drug Name Search

Transipen




Transipen may be available in the countries listed below.


Ingredient matches for Transipen



Indapamide

Indapamide hemihydrate (a derivative of Indapamide) is reported as an ingredient of Transipen in the following countries:


  • Greece

International Drug Name Search

Saturday 10 October 2009

Tolonium Chloride




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000092-31-9

Chemical Formula

C15-H16-Cl-N3-S

Molecular Weight

305

Therapeutic Categories

Hemostatic agent

Antidote in methemoglobinemia

Chemical Name

Phenothiazin-5-ium, 3-amino-7-(dimethylamino)-2-methyl-, chloride

Foreign Names

  • Tolonii Chloridum (Latin)
  • Tolonium chlorid (German)
  • Chlorure de Tolonium (French)
  • Cloruro de tolonio (Spanish)

Generic Names

  • $Io$R-Toluidine blue (IS)
  • CI 52040 (IS)

Brand Names

  • Oratest
    Intertrade, Greece


  • Toluidinblau
    Köhler, Germany

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ketozal




Ketozal may be available in the countries listed below.


Ingredient matches for Ketozal



Ketoconazole

Ketoconazole is reported as an ingredient of Ketozal in the following countries:


  • Bulgaria

International Drug Name Search

Lostradyl




Lostradyl may be available in the countries listed below.


Ingredient matches for Lostradyl



Nitrendipine

Nitrendipine is reported as an ingredient of Lostradyl in the following countries:


  • Greece

International Drug Name Search

Oftalmolets




Oftalmolets may be available in the countries listed below.


Ingredient matches for Oftalmolets



Erythromycin

Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Oftalmolets in the following countries:


  • Argentina

International Drug Name Search

Thursday 8 October 2009

Volley




Volley may be available in the countries listed below.


Ingredient matches for Volley



Butenafine

Butenafine hydrochloride (a derivative of Butenafine) is reported as an ingredient of Volley in the following countries:


  • Japan

International Drug Name Search

Tuesday 6 October 2009

Corotrend




Corotrend may be available in the countries listed below.


Ingredient matches for Corotrend



Nifedipine

Nifedipine is reported as an ingredient of Corotrend in the following countries:


  • Switzerland

International Drug Name Search

Monday 5 October 2009

IGR




IGR may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for IGR



Triflumuron

Triflumuron is reported as an ingredient of IGR in the following countries:


  • Australia

International Drug Name Search

Penicilina G Sodica Richet




Penicilina G Sodica Richet may be available in the countries listed below.


Ingredient matches for Penicilina G Sodica Richet



Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicilina G Sodica Richet in the following countries:


  • Argentina

International Drug Name Search

Sunday 4 October 2009

Adrome




Adrome may be available in the countries listed below.


Ingredient matches for Adrome



Carbazochrome

Carbazochrome sodium sulfonate (a derivative of Carbazochrome) is reported as an ingredient of Adrome in the following countries:


  • Indonesia

International Drug Name Search

Thursday 1 October 2009

Apo-Pentoxifylline




Apo-Pentoxifylline may be available in the countries listed below.


Ingredient matches for Apo-Pentoxifylline



Pentoxifylline

Pentoxifylline is reported as an ingredient of Apo-Pentoxifylline in the following countries:


  • Canada

  • Czech Republic

  • Guyana

  • Vietnam

International Drug Name Search

Friday 25 September 2009

Entocort Klysma




Entocort Klysma may be available in the countries listed below.


Ingredient matches for Entocort Klysma



Budesonide

Budesonide is reported as an ingredient of Entocort Klysma in the following countries:


  • Netherlands

International Drug Name Search

Thursday 24 September 2009

Kanamycin Virbac




Kanamycin Virbac may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Kanamycin Virbac



Kanamycin

Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Kanamycin Virbac in the following countries:


  • Austria

International Drug Name Search

Wednesday 23 September 2009

Xylocaine Viscous




In the US, Xylocaine Viscous (lidocaine topical) is a member of the drug class topical anesthetics and is used to treat Anesthesia and Pain.

US matches:

  • Xylocaine Viscous Solution

  • Xylocaine Viscous

Ingredient matches for Xylocaine Viscous



Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xylocaine Viscous in the following countries:


  • New Zealand

  • Taiwan

International Drug Name Search

Tuesday 22 September 2009

Mesalazina Dorom




Mesalazina Dorom may be available in the countries listed below.


Ingredient matches for Mesalazina Dorom



Mesalazine

Mesalazine is reported as an ingredient of Mesalazina Dorom in the following countries:


  • Italy

International Drug Name Search

Saturday 19 September 2009

Dolex




Dolex may be available in the countries listed below.


Ingredient matches for Dolex



Clonixin

Clonixin lysine salt (a derivative of Clonixin) is reported as an ingredient of Dolex in the following countries:


  • Argentina

Paracetamol

Paracetamol is reported as an ingredient of Dolex in the following countries:


  • Colombia

International Drug Name Search

Thursday 17 September 2009

Spironolactone Altizide Arrow




Spironolactone Altizide Arrow may be available in the countries listed below.


Ingredient matches for Spironolactone Altizide Arrow



Altizide

Altizide is reported as an ingredient of Spironolactone Altizide Arrow in the following countries:


  • France

Spironolactone

Spironolactone is reported as an ingredient of Spironolactone Altizide Arrow in the following countries:


  • France

International Drug Name Search

Saturday 12 September 2009

Diaformina




Diaformina may be available in the countries listed below.


Ingredient matches for Diaformina



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Diaformina in the following countries:


  • Venezuela

International Drug Name Search

Wednesday 9 September 2009

Glicirex




Glicirex may be available in the countries listed below.


Ingredient matches for Glicirex



Gliclazide

Gliclazide is reported as an ingredient of Glicirex in the following countries:


  • Czech Republic

International Drug Name Search

Monday 7 September 2009

Retin-A Micro Topical


Generic Name: tretinoin (Topical route)

TRET-i-noin

Commonly used brand name(s)

In the U.S.


  • Atralin

  • Avita

  • Refissa

  • Renova

  • Retin-A

  • Retin-A Micro

  • Tretin-X

In Canada


  • Rejuva-A

  • Stieva-A Cream

  • Stieva-A Cream Forte

  • Stieva-A Gel

  • Stieva-A Solution

  • Vitamin A Acid

Available Dosage Forms:


  • Gel/Jelly

  • Solution

  • Liquid

  • Cream

Therapeutic Class: Dermatological Agent


Chemical Class: Retinoid


Uses For Retin-A Micro


Tretinoin is used to treat acne. It works partly by keeping skin pores clear.


One of the tretinoin creams is used to treat fine wrinkles, dark spots, or rough skin on the face caused by damaging rays of the sun. It works by lightening the skin, replacing older skin with newer skin, and by slowing down the way the body removes skin cells that may have been harmed by the sun. Tretinoin works best when used within a skin care program that includes protecting the treated skin from the sun. However, it does not completely or permanently erase these skin problems or greatly improve more obvious changes in the skin, such as deep wrinkles caused by sun or the natural aging process.


Tretinoin may also be used to treat other skin diseases as determined by your doctor.


Tretinoin is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, tretinoin is used in certain patients with the following medical conditions:


  • Keratosis follicularis (skin disorder of small, red bumps)

  • Verruca plana (flat warts)

Before Using Retin-A Micro


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of this medicine in children with use in other age groups. Children are unlikely to have skin problems due to the sun. In older children treated for acne, tretinoin is not expected to cause different side effects or problems than it does in other age groups.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of tretinoin in patients 50 years of age and older with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Aminocaproic Acid

  • Aprotinin

  • Tetracycline

  • Tranexamic Acid

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Fluconazole

  • Ketoconazole

  • Voriconazole

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Dermatitis, seborrheic or

  • Eczema or

  • Sunburn—Use of this medicine may cause or increase the irritation associated with these problems

Proper Use of tretinoin

This section provides information on the proper use of a number of products that contain tretinoin. It may not be specific to Retin-A Micro. Please read with care.


It is very important that you use this medicine only as directed. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause irritation of the skin.


Do not apply this medicine to windburned or sunburned skin or on open wounds.


Do not use this medicine in or around the eyes or lips, or inside of the nose. Spread the medicine away from these areas when applying. If the medicine accidentally gets on these areas, wash with water at once.


This medicine usually comes with patient directions. Read them carefully before using the medicine.


Before applying tretinoin, wash the skin with a mild soap or cleanser and warm water by using the tips of your fingers. Then gently pat dry. Do not scrub your face with a sponge or washcloth. Wait 20 to 30 minutes before applying this medicine to make sure the skin is completely dry. Applying tretinoin to wet skin can irritate the skin.


To use the cream or gel form of this medicine:


  • Apply just enough medicine to very lightly cover the affected areas, and rub in gently but well. A pea-sized amount is enough to cover the whole face.

To use the solution form of this medicine:


  • Using your fingertips, a gauze pad, or a cotton swab, apply enough tretinoin solution to cover the affected areas. If you use a gauze pad or a cotton swab for applying the medicine, avoid getting it too wet. This will help prevent the medicine from running into areas not intended for treatment.

After applying the medicine, wash your hands to remove any medicine that might remain on them.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For topical dosage forms (cream, gel, or solution):
    • For acne:
      • Adults and teenagers—Apply to the affected area(s) of the skin once a day, at bedtime.



  • For cream dosage form (brand name Renova only):
    • For fine wrinkles, dark spots, or rough skin caused by the sun:
      • Adults up to 50 years of age—Apply to the affected area(s) of the skin once a day, at bedtime.

      • Adults 50 years of age and older—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


The gel product is flammable and should be kept away from fire or excessive heat.


Precautions While Using Retin-A Micro


During the first 3 weeks you are using tretinoin, your skin may become irritated. Also, your acne may seem to get worse before it gets better. It may take longer than 12 weeks before you notice full improvement of your acne, even if you use the medicine every day. Check with your health care professional at any time skin irritation becomes severe or if your acne does not improve within 8 to 12 weeks.


You should avoid washing the skin treated with tretinoin for at least 1 hour after applying it.


Avoid using any topical medicine on the same area within 1 hour before or after using tretinoin. Otherwise, tretinoin may not work properly or skin irritation might occur.


Unless your doctor tells you otherwise, it is especially important to avoid using the following skin products on the same area as tretinoin:


  • Any other topical acne product or skin product containing a peeling agent (such as benzoyl peroxide, resorcinol, salicylic acid, or sulfur)

  • Hair products that are irritating, such as permanents or hair removal products

  • Skin products that cause sensitivity to the sun, such as those containing spices or limes

  • Skin products containing a large amount of alcohol, such as astringents, shaving creams, or after-shave lotions

  • Skin products that are too drying or abrasive, such as some cosmetics, soaps, or skin cleansers

Using these products along with tretinoin may cause mild to severe irritation of the skin. Although skin irritation can occur, some doctors sometimes allow benzoyl peroxide to be used with tretinoin to treat acne. Usually tretinoin is applied at night so that it does not cause a problem with any other topical products that you might use during the day. Check with your doctor before using topical medicines with tretinoin.


During the first 6 months of use, avoid overexposing the treated areas to sunlight, wind, or cold weather. The skin will be more prone to sunburn, dryness, or irritation, especially during the first 2 or 3 weeks. However, you should not stop using this medicine unless the skin irritation becomes too severe. Do not use a sunlamp .


To help tretinoin work properly, regularly use sunscreen or sunblocking lotions with a sun protection factor (SPF) of at least 15. Also, wear protective clothing and hats, and apply creams, lotions, or moisturizers often.


Check with your doctor at any time your skin becomes too dry and irritated. Your health care professional can help you choose the right skin products for you to reduce skin dryness and irritation and may include the following:


  • For patients using tretinoin for the treatment of acne:
    • Regular use of water-based creams or lotions helps to reduce skin irritation or dryness that may be caused by the use of tretinoin.


  • For patients using tretinoin for the treatment of fine wrinkling, dark spots, and rough skin caused by the sun:
    • This medicine should be used as part of an ongoing program to avoid further damage to your skin from the sun. This program includes staying out of the sun when possible or wearing proper clothing or hats to protect your skin from sunlight.

    • Regular use of oil-based creams or lotions helps to reduce skin irritation or dryness caused by the use of tretinoin.


Retin-A Micro Side Effects


In some animal studies, tretinoin has been shown to cause skin tumors to develop faster when the treated area is exposed to ultraviolet light (sunlight or artificial sunlight from a sunlamp). Other studies have not shown the same result and more studies need to be done. It is not known if tretinoin causes skin tumors to develop faster in humans.


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


More common
  • Burning feeling or stinging skin (severe)

  • lightening of skin of treated area, unexpected

  • peeling of skin (severe)

  • redness of skin (severe)

  • unusual dryness of skin (severe)

Rare
  • Darkening of treated skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Burning feeling, stinging, or tingling of skin (mild)—lasting for a short time after first applying the medicine

  • chapping or slight peeling of skin (mild)

  • redness of skin (mild)

  • unusual dryness of skin (mild)

  • unusually warm skin (mild)

The side effects will go away after you stop using tretinoin. On the rare chance that your skin color changes, this effect may last for several months before your skin color returns to normal.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Retin-A Micro Topical resources


  • Retin-A Micro Topical Use in Pregnancy & Breastfeeding
  • Retin-A Micro Topical Drug Interactions
  • Retin-A Micro Topical Support Group
  • 42 Reviews for Retin-A Micro Topical - Add your own review/rating


Compare Retin-A Micro Topical with other medications


  • Acne
  • Lichen Sclerosus
  • Necrobiosis Lipoidica Diabeticorum
  • Photoaging of the Skin

Friday 4 September 2009

Microvit H




Microvit H may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Microvit H



Biotin

Biotin is reported as an ingredient of Microvit H in the following countries:


  • Australia

International Drug Name Search

Thursday 3 September 2009

Bright Beginnings Prenatal Bar


Pronunciation: pree-NATE-al VYE-ta-mins
Generic Name: Prenatal Multivitamins and Minerals with Iron and Folic Acid
Brand Name: Examples include Bright Beginnings Prenatal Bar and Vinatal


Bright Beginnings Prenatal Bar is used for:

Treating or preventing a lack of vitamins or minerals before, during, and after pregnancy and while breast-feeding. Treating or preventing certain conditions as determined by your doctor.


Do NOT use Bright Beginnings Prenatal Bar if:


  • you are allergic to any ingredient in Bright Beginnings Prenatal Bar

  • you have hemochromatosis (a disorder of iron metabolism) or Wilson disease (a disorder of copper metabolism)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Bright Beginnings Prenatal Bar:


Some medical conditions may interact with Bright Beginnings Prenatal Bar. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a bowel disorder (eg, colitis, Crohn disease, diverticulitis), certain blood disorders (eg, hemolytic or pernicious anemia, porphyria cutanea tarda, thalassemia), or peptic ulcer

  • if you have had multiple blood transfusions

Some MEDICINES MAY INTERACT with Bright Beginnings Prenatal Bar. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Cation exchange resins (eg, sodium polystyrene sulfonate) because side effects, including increased risk of muscle twitches and tremors, nausea, vomiting, numbness in face or extremities, and confusion possibly leading to coma, may be increased by Bright Beginnings Prenatal Bar.

  • Acitretin, cyclosporine, fluorouracil, and quinidine because actions and side effects may be increased by Bright Beginnings Prenatal Bar.

  • Hydantoins (eg, phenytoin), mycophenolate, or penicillamine because the effectiveness may be decreased by Bright Beginnings Prenatal Bar.

  • Oral anticoagulants (eg, warfarin) because side effects, including risk of bleeding, may be increased by Bright Beginnings Prenatal Bar.

This may not be a complete list of all interactions that may occur. Ask your health care provider if Bright Beginnings Prenatal Bar may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Bright Beginnings Prenatal Bar:


Use Bright Beginnings Prenatal Bar as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Check with your pharmacist to see if your brand should be taken with food or on an empty stomach. If stomach upset occurs, take with food to reduce stomach irritation.

  • Take Bright Beginnings Prenatal Bar with a full glass of water.

  • Avoid taking Bright Beginnings Prenatal Bar with dairy products as they may interfere with the absorption of the iron in Bright Beginnings Prenatal Bar.

  • If you are taking one of the following oral medicines, separate their administration by at least 2 hours: angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril), azole antifungals (eg, ketoconazole), bisphosphonates (eg, etidronate), cation exchange resins (eg, sodium polystyrene sulfonate), cephalosporins (eg, cephalexin), delavirdine, digoxin, oral corticosteroids (eg, prednisone), quinolones (eg, ciprofloxacin), sulfonylureas (eg, glyburide), or thyroid hormones (eg, levothyroxine).

  • If taking Bright Beginnings Prenatal Bar with methyldopa, levodopa, or tetracyclines (eg, doxycycline), administer at least 3 hours apart.

  • If you miss a dose of Bright Beginnings Prenatal Bar, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Bright Beginnings Prenatal Bar.



Important safety information:


  • While you are taking Bright Beginnings Prenatal Bar you may notice darkening of stools. This is normal.

  • Bright Beginnings Prenatal Bar contains iron. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children younger than 6 years of age. In case of accidental overdose, call a doctor or poison control center immediately.


Possible side effects of Bright Beginnings Prenatal Bar:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; nausea; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; stomach pain or cramping.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Bright Beginnings Prenatal side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include diarrhea; headache; lack of feeling alert; loss of balance; nausea; vomiting.


Proper storage of Bright Beginnings Prenatal Bar:

Store Bright Beginnings Prenatal Bar at room temperature between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Bright Beginnings Prenatal Bar out of the reach of children and away from pets.


General information:


  • If you have any questions about Bright Beginnings Prenatal Bar, please talk with your doctor, pharmacist, or other health care provider.

  • Bright Beginnings Prenatal Bar is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Bright Beginnings Prenatal Bar. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Bright Beginnings Prenatal resources


  • Bright Beginnings Prenatal Side Effects (in more detail)
  • Bright Beginnings Prenatal Use in Pregnancy & Breastfeeding
  • Bright Beginnings Prenatal Drug Interactions
  • Bright Beginnings Prenatal Support Group
  • 0 Reviews for Bright Beginnings Prenatal - Add your own review/rating


Compare Bright Beginnings Prenatal with other medications


  • Vitamin/Mineral Supplementation during Pregnancy/Lactation

Wednesday 2 September 2009

Gelbiotic




Gelbiotic may be available in the countries listed below.


Ingredient matches for Gelbiotic



Fusidic Acid

Fusidic Acid is reported as an ingredient of Gelbiotic in the following countries:


  • Argentina

International Drug Name Search

Friday 21 August 2009

Impromen




Impromen may be available in the countries listed below.


Ingredient matches for Impromen



Bromperidol

Bromperidol is reported as an ingredient of Impromen in the following countries:


  • Belgium

  • Italy

  • Japan

  • Luxembourg

  • Netherlands

Bromperidol decanoate (a derivative of Bromperidol) is reported as an ingredient of Impromen in the following countries:


  • Belgium

International Drug Name Search

Monday 17 August 2009

Visine Advance Allergy




Visine Advance Allergy may be available in the countries listed below.


Ingredient matches for Visine Advance Allergy



Naphazoline

Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Visine Advance Allergy in the following countries:


  • Canada

Pheniramine

Pheniramine maleate (a derivative of Pheniramine) is reported as an ingredient of Visine Advance Allergy in the following countries:


  • Canada

International Drug Name Search

Sunday 16 August 2009

Amlist




Amlist may be available in the countries listed below.


Ingredient matches for Amlist



Amlodipine

Amlodipine maleate (a derivative of Amlodipine) is reported as an ingredient of Amlist in the following countries:


  • Ireland

International Drug Name Search

Folsäure-Hevert




Folsäure-Hevert may be available in the countries listed below.


Ingredient matches for Folsäure-Hevert



Folic Acid

Folic Acid is reported as an ingredient of Folsäure-Hevert in the following countries:


  • Germany

International Drug Name Search

Tuesday 11 August 2009

Alminth




Alminth may be available in the countries listed below.


Ingredient matches for Alminth



Albendazole

Albendazole is reported as an ingredient of Alminth in the following countries:


  • Bahrain

  • Ethiopia

International Drug Name Search

Dermazinc Cream


Pronunciation: AN-tye-seb-oh-REE-ik
Generic Name: Antiseborrheic
Brand Name: Examples include Dermazinc and Promiseb


Dermazinc Cream is used for:

Relieving signs and symptoms of seborrhea and seborrheic dermatitis, such as itching, redness, scaling, and pain. It may also be used for other conditions as determined by your doctor.


Dermazinc Cream is an antiseborrheic. It works by helping to provide moisture to the affected area.


Do NOT use Dermazinc Cream if:


  • you are allergic to any ingredient in Dermazinc Cream

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dermazinc Cream:


Some medical conditions may interact with Dermazinc Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances (eg, nuts)

Some MEDICINES MAY INTERACT with Dermazinc Cream. However, no specific interactions with Dermazinc Cream are known at this time.


Ask your health care provider if Dermazinc Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dermazinc Cream:


Use Dermazinc Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Apply Dermazinc Cream to the affected area as directed by your doctor. Massage the cream gently into the skin.

  • If the skin is broken, you may cover the area after applying Dermazinc Cream, unless your doctor tells you otherwise.

  • If you miss a dose of Dermazinc Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Dermazinc Cream.



Important safety information:


  • Dermazinc Cream is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in any of these areas, rinse right away with cool water.

  • Do not apply Dermazinc Cream over large areas of your body without first checking with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dermazinc Cream while you are pregnant. It is not known if Dermazinc Cream is found in breast milk after topical use. If you are or will be breast-feeding while you use Dermazinc Cream, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Dermazinc Cream:


All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dermazinc side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org/DNN/), or emergency room immediately.


Proper storage of Dermazinc Cream:

Store Dermazinc Cream between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Do not use if the metal seal has been broken. Keep Dermazinc Cream out of the reach of children and away from pets.


General information:


  • If you have any questions about Dermazinc Cream, please talk with your doctor, pharmacist, or other health care provider.

  • Dermazinc Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dermazinc Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dermazinc resources


  • Dermazinc Side Effects (in more detail)
  • Dermazinc Use in Pregnancy & Breastfeeding
  • Dermazinc Support Group
  • 0 Reviews for Dermazinc - Add your own review/rating


Compare Dermazinc with other medications


  • Dandruff
  • Seborrheic Dermatitis

Saturday 8 August 2009

Zodac




Zodac may be available in the countries listed below.


Ingredient matches for Zodac



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Zodac in the following countries:


  • Czech Republic

  • Georgia

  • Poland

  • Russian Federation

  • Slovakia

International Drug Name Search

Friday 7 August 2009

Azatioprina Dosa




Azatioprina Dosa may be available in the countries listed below.


Ingredient matches for Azatioprina Dosa



Azathioprine

Azathioprine is reported as an ingredient of Azatioprina Dosa in the following countries:


  • Argentina

International Drug Name Search

Tuesday 4 August 2009

Adevirock




Adevirock may be available in the countries listed below.


Ingredient matches for Adevirock



Elcatonin

Elcatonin is reported as an ingredient of Adevirock in the following countries:


  • Japan

International Drug Name Search

Sulfacetamide Sodium




Ingredient matches for Sulfacetamide Sodium



Sulfacetamide Sodium

Sulfacetamide Sodium (BANM) is known as Sulfacetamide Sodium in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 3 August 2009

Norflox-1A Pharma




Norflox-1A Pharma may be available in the countries listed below.


Ingredient matches for Norflox-1A Pharma



Norfloxacin

Norfloxacin is reported as an ingredient of Norflox-1A Pharma in the following countries:


  • Germany

International Drug Name Search

Sunday 2 August 2009

Pacliteva




Pacliteva may be available in the countries listed below.


Ingredient matches for Pacliteva



Paclitaxel

Paclitaxel is reported as an ingredient of Pacliteva in the following countries:


  • Argentina

International Drug Name Search

Tazobax




Tazobax may be available in the countries listed below.


Ingredient matches for Tazobax



Piperacillin

Piperacillin is reported as an ingredient of Tazobax in the following countries:


  • South Africa

Tazobactam

Tazobactam is reported as an ingredient of Tazobax in the following countries:


  • South Africa

International Drug Name Search

P.L.H.




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for P.L.H.



Lutropin Alfa

Lutropin Alfa is reported as an ingredient of P.L.H. in the following countries:


  • United States

International Drug Name Search

Saturday 1 August 2009

Gerivent




Gerivent may be available in the countries listed below.


Ingredient matches for Gerivent



Salbutamol

Salbutamol is reported as an ingredient of Gerivent in the following countries:


  • Ireland

International Drug Name Search

Deprim




Deprim may be available in the countries listed below.


Ingredient matches for Deprim



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Deprim in the following countries:


  • Cyprus

  • Ethiopia

  • Ghana

  • Kenya

  • New Zealand

  • Oman

  • Tanzania

Trimethoprim

Trimethoprim is reported as an ingredient of Deprim in the following countries:


  • Cyprus

  • Ethiopia

  • Ghana

  • Kenya

  • New Zealand

  • Oman

  • Tanzania

International Drug Name Search

Monday 27 July 2009

Zidovudina Biomendi




Zidovudina Biomendi may be available in the countries listed below.


Ingredient matches for Zidovudina Biomendi



Zidovudine

Zidovudine is reported as an ingredient of Zidovudina Biomendi in the following countries:


  • Spain

International Drug Name Search

Sunday 26 July 2009

Zolpidem Genthon




Zolpidem Genthon may be available in the countries listed below.


Ingredient matches for Zolpidem Genthon



Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem Genthon in the following countries:


  • Luxembourg

International Drug Name Search

Friday 24 July 2009

Kétoconazole Arrow




Kétoconazole Arrow may be available in the countries listed below.


Ingredient matches for Kétoconazole Arrow



Ketoconazole

Ketoconazole is reported as an ingredient of Kétoconazole Arrow in the following countries:


  • France

International Drug Name Search

Thursday 23 July 2009

Diflubenzuron




In some countries, this medicine may only be approved for veterinary use.

CAS registry number (Chemical Abstracts Service)

0035367-38-5

Chemical Formula

C14-H9-Cl-F2-N2-O2

Molecular Weight

310

Therapeutic Category

Insecticide

Chemical Name

Benzamide, N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluoro-

Foreign Name

  • Diflubenzuron (German)

Generic Name

  • Difluron (IS)

Brand Names

  • Blitz (veterinary use)
    Intervet / Schering-Plough Animal Health, New Zealand


  • Device (veterinary use)
    Bleu Line, Italy


  • Ectogard (veterinary use)
    Novartis Animal Health, New Zealand


  • Fleececare (veterinary use)
    Intervet, South Africa; Virbac, Australia


  • Fleecemaster (veterinary use)
    Merial Ancare, New Zealand


  • MAGiK (Diflubenzuron and Dicyclanil (veterinary use))
    Novartis Animal Health Australasia, Australia


  • Magnum (veterinary use)
    Coopers Animal Health, Australia; Intervet / Schering-Plough Animal Health, New Zealand


  • Stampede (veterinary use)
    Virbac, Australia


  • Strike (veterinary use)
    Coopers Animal Health, Australia


  • Zenith (veterinary use)
    Intervet / Schering-Plough Animal Health, New Zealand

International Drug Name Search

Glossary

ISInofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Zevalin




In the US, Zevalin (ibritumomab systemic) is a member of the following drug classes: CD20 monoclonal antibodies, radiologic conjugating agents and is used to treat Non-Hodgkin's Lymphoma.

US matches:

  • Zevalin In-111

  • Zevalin Y-90

  • Zevalin

UK matches:

  • Zevalin 1.6 mg/ml, Kit for radiopharmaceutical preparation for infusion (SPC)

Ingredient matches for Zevalin



Ibritumomab

Ibritumomab Tiuxetan is reported as an ingredient of Zevalin in the following countries:


  • Austria

  • Belgium

  • Canada

  • Croatia (Hrvatska)

  • Finland

  • France

  • Germany

  • Hungary

  • Ireland

  • Israel

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Poland

  • Romania

  • Slovenia

  • South Africa

  • Sweden

  • Switzerland

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Migard




Migard may be available in the countries listed below.


UK matches:

  • Migard
  • Migard (A.Menarini Pharma U.K. S.R.L.) (SPC)

Ingredient matches for Migard



Frovatriptan

Frovatriptan is reported as an ingredient of Migard in the following countries:


  • Latvia

Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Migard in the following countries:


  • Denmark

  • Estonia

  • Finland

  • Germany

  • Lithuania

  • Luxembourg

  • Portugal

  • Slovakia

  • Slovenia

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 22 July 2009

Flexiban




Flexiban may be available in the countries listed below.


Ingredient matches for Flexiban



Cyclobenzaprine

Cyclobenzaprine hydrochloride (a derivative of Cyclobenzaprine) is reported as an ingredient of Flexiban in the following countries:


  • Italy

  • Portugal

International Drug Name Search

Sunday 19 July 2009

Zatral




Zatral may be available in the countries listed below.


Ingredient matches for Zatral



Alfuzosin

Alfuzosin is reported as an ingredient of Zatral in the following countries:


  • Bangladesh

International Drug Name Search

Friday 10 July 2009

Polycef




Polycef may be available in the countries listed below.


Ingredient matches for Polycef



Cefradine

Cefradine is reported as an ingredient of Polycef in the following countries:


  • Bangladesh

International Drug Name Search

Thursday 2 July 2009

Zenafluk




Zenafluk may be available in the countries listed below.


Ingredient matches for Zenafluk



Fluconazole

Fluconazole is reported as an ingredient of Zenafluk in the following countries:


  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Estonia

  • Latvia

  • Lithuania

International Drug Name Search

Sunday 28 June 2009

Cantabilin




Cantabilin may be available in the countries listed below.


Ingredient matches for Cantabilin



Hymecromone

Hymecromone is reported as an ingredient of Cantabilin in the following countries:


  • Italy

  • Turkey

International Drug Name Search

Saturday 27 June 2009

Betamethasone Solution



Pronunciation: bay-ta-METH-a-sone
Generic Name: Betamethasone
Brand Name: Celestone


Betamethasone Solution is used for:

Treating severe allergies, arthritis, asthma, multiple sclerosis, and skin conditions. It may also be used for other conditions as determined by your doctor.


Betamethasone Solution is a corticosteroid. It works by decreasing or preventing tissues from responding to inflammation. It also modifies the body's response to certain immune stimulation.


Do NOT use Betamethasone Solution if:


  • you are allergic to any ingredient in Betamethasone Solution

  • you have a systemic fungal infection

  • you are taking mifepristone or are scheduled for a smallpox vaccination

Contact your doctor or health care provider right away if any of these apply to you.



Before using Betamethasone Solution:


Some medical conditions may interact with Betamethasone Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have recently had or are scheduled to have a vaccination

  • if you have a history of an underactive thyroid, liver or kidney problems, heart problems or heart attack, diabetes, high blood pressure, inflammation of the esophagus, stomach problems (eg, ulcers), bowel blockage or other bowel problems (eg, ulcerative colitis), recent bowel surgery, myasthenia gravis, bone problems (eg, osteoporosis), or mental or mood problems (eg, depression)

  • if you have diarrhea, measles, chickenpox, herpes infection of the eye, or any other type of bacterial, fungal, parasitic, or viral infection

  • if you have recently had tuberculosis (TB) or have had a positive skin test for TB

Some MEDICINES MAY INTERACT with Betamethasone Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Aprepitant because they may increase the risk of Betamethasone Solution's side effects

  • Barbiturates (eg, phenobarbital), carbamazepine, hydantoins (eg, phenytoin), or rifampin because they may decrease Betamethasone Solution's effectiveness

  • Clarithromycin, azole antifungals (eg, ketoconazole), steroidal contraceptives (eg, desogestrel), or troleandomycin because side effects, such as weakness, confusion, muscle aches, joint pain, or low blood sugar, may occur

  • Methotrexate or ritodrine because the risk of their side effects may be increased by Betamethasone Solution

  • Hydantoins (eg, phenytoin), live vaccines. or mifepristone because their effectiveness may be decreased by Betamethasone Solution

  • Anticoagulants (eg, warfarin) or aspirin because the actions and side effects of these medicines may be increased or decreased by Betamethasone Solution

This may not be a complete list of all interactions that may occur. Ask your health care provider if Betamethasone Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Betamethasone Solution:


Use Betamethasone Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Betamethasone Solution by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Use the dropper that comes with Betamethasone Solution to measure your dose. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If Betamethasone Solution needs to be stopped (or if a different medicine is added to therapy) by your doctor, this will be done gradually. The risk of side effects may be increased if Betamethasone Solution is suddenly stopped.

  • If you miss a dose of Betamethasone Solution, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Betamethasone Solution.



Important safety information:


  • Betamethasone Solution may cause dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Betamethasone Solution with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Betamethasone Solution may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

  • If you have not had chickenpox, shingles, or measles, avoid contact with anyone who does.

  • Carry an ID card at all times that says you take Betamethasone Solution.

  • Tell your doctor or dentist that you take Betamethasone Solution before you receive any medical or dental care, emergency care, or surgery.

  • Long-term use may cause cataracts, glaucoma, and eye infections. Contact your doctor right away if you develop any unusual changes in your vision.

  • Betamethasone Solution may cause an increase in blood pressure, salt and water retention, and calcium and potassium loss. Talk with your doctor to see if you need to decrease the amount of salt in your diet or take a potassium, calcium, or vitamin D supplement.

  • Do not receive a live vaccine (eg, measles, mumps) while you are taking Betamethasone Solution. Talk with your doctor before you receive any vaccine.

  • Diabetes patients - Betamethasone Solution may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • Lab tests, including blood electrolytes, blood calcium levels, blood pressure, and vision tests, may be performed while you use Betamethasone Solution. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Caution is advised when using Betamethasone Solution in CHILDREN; they may be more sensitive to its effects.

  • Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they take Betamethasone Solution.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Betamethasone Solution while you are pregnant. It is not known if Betamethasone Solution is found in breast milk. If you are or will be breast-feeding while you use Betamethasone Solution, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Betamethasone Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Difficulty sleeping; dizziness or lightheadedness; headache; increased appetite; increased sweating; indigestion; nervousness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; changes in menstrual periods; chest pain; eye pain or increased pressure in the eye; fever, chills, or sore throat; joint or bone pain; mood or mental changes (eg, depression); muscle pain or weakness; seizures; severe or persistent nausea or vomiting; stomach pain or bloating; swelling of feet or legs; trouble sleeping; unusual weight gain or loss; vision changes; vomiting material that looks like coffee grounds.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Betamethasone Solution:

Store Betamethasone Solution at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Betamethasone Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Betamethasone Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Betamethasone Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Betamethasone Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Betamethasone resources


  • Betamethasone Use in Pregnancy & Breastfeeding
  • Betamethasone Drug Interactions
  • Betamethasone Support Group
  • 1 Review for Betamethasone - Add your own review/rating


Compare Betamethasone with other medications


  • Bursitis
  • Dermatological Disorders
  • Gouty Arthritis
  • Inflammatory Conditions
  • Osteoarthritis